A high dose cholecalciferol, a form of vitamin D, significantly reduced the risk of further disease activity in people with clinically isolated syndrome (CIS), published findings from a Phase 3 trial… [+4729 chars]
High-dose vitamin D may stop CIS, early RRMS new disease activity - Multiple Sclerosis News Today
Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.
By:Lindsey Shapiro, PhD
Source:Multiple Sclerosis News Today
Published:
Related News
Study Reveals How Much Exercise You Need Weekly To Control Blood Pressure - ScienceAlert
When it comes to exercising for your heart's sake, you don't want to peak too early in life.
ScienceAlert•Clare Watson
Scientists May Have Found a Blueprint to Revive Old Cells - ScienceAlert
Many of the body's processes slow down or falter as we get older, including tissue regeneration.
ScienceAlert•David Nield
San Francisco reports first flu deaths of the season as cases rise across California - San Francisco Chronicle
San Francisco on Friday announced the city’s first two flu deaths of the winter respiratory virus season, as cases rise across California.
San Francisco Chronicle•Catherine Ho